XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenues:        
Total revenues $ 21,323 $ 38,406 $ 34,305 $ 73,746
Costs and operating expenses:        
Cost of product revenue 3,178 11,270 7,698 19,791
Research and development 17,334 19,089 33,988 38,590
Selling, general and administrative 13,365 10,656 28,765 26,360
Restructuring charges 72 0 145 0
Total costs and operating expenses 33,949 41,015 70,596 84,741
Loss from operations (12,626) (2,609) (36,291) (10,995)
Interest income 1,121 140 2,209 182
Other expense, net (9) (63) (33) (66)
Loss before income taxes (11,514) (2,532) (34,115) (10,879)
Provision for income taxes 9 108 25 117
Net loss $ (11,523) $ (2,640) $ (34,140) $ (10,996)
Net loss per share, basic (in dollars per share) $ (0.17) $ (0.04) $ (0.51) $ (0.17)
Net loss per share, diluted (in dollars per share) $ (0.17) $ (0.04) $ (0.51) $ (0.17)
Weighted average common stock shares used in computing net loss per share, basic (in shares) 67,573 65,288 66,756 65,193
Weighted average common stock shares used in computing net loss per share, diluted (in shares) 67,573 65,288 66,756 65,193
Product revenue        
Revenues:        
Total revenues $ 11,048 $ 34,645 $ 19,412 $ 65,335
Research and development revenue        
Revenues:        
Total revenues $ 10,275 $ 3,761 $ 14,893 $ 8,411